A revolutionary new AI-powered blood test is being rolled out in NHS hospitals across England to assess women referred for possible womb cancer before invasive checks are carried out. The technology uses a combination of machine learning algorithms and genetic analysis to detect subtle changes in the blood that may indicate an increased risk of womb cancer.
According to reports, around 90,000 postmenopausal women in England each year are referred by general practitioners (GPs) for checks after experiencing heavy bleeding. Of these, approximately 10,000 are diagnosed with womb cancer every year, resulting in significant morbidity and mortality for those affected. The new test aims to identify individuals who may benefit from earlier intervention, potentially saving lives.
The NHS AI blood test is being piloted at several hospitals across the country, with plans to roll it out nationwide in the coming months. While more research is needed to fully understand its accuracy and effectiveness, officials are cautiously optimistic about the potential benefits of this innovative approach. As one hospital official noted, "This could be a game-changer for women's health in England."